News and Updates

A high-profile heart failure device trial has been abandoned, highlighting the risks of medical innovation and the hurdles facing breakthrough technology.

Revolution Medicines has launched the RASolute 305 trial testing zoldonrasib for G12D-mutant pancreatic cancer, targeting a major milestone in oncology.

Sponsor mergers are causing clinical trial delays. Discover how site-level operational burdens impact patient care and study success in our latest report.

Pfizer's sigvotatug vedotin fails to meet primary survival goals in a Phase 3 lung cancer trial. Read the latest clinical update on this ADC candidate.

Discover why clinical trial data integrity starts at the source. Learn how real-time monitoring and digital tools ensure regulatory success and accuracy.

Discover how early biomarkers are revolutionizing nephrology clinical trials, reducing study failure rates, and accelerating essential renal drug development.

Discover evidence-based strategies for treating platinum-resistant ovarian cancer when clinical trials are not an option. Learn about key systemic therapies.

A groundbreaking clinical trial has launched, treating the first Huntington's disease patient with neural stem cell therapy to combat neurodegeneration.

Discover how new clinical trial guidelines, effective this September, will reshape drug development, enhance patient safety, and improve research standards.

HHS and FDA propose major reforms to streamline clinical trials and accelerate drug development, focusing on decentralized models and real-world evidence.